KREBS BIOCHEMICALS & IND (KREBSBIO)

NSE: ₹65.54
BSE: ₹65.00
Stock Performance
Corporate Announcements
Compliances-Reg.24(A)-Annual Secretarial Compliance

The Company has enclosed herewith Annual Secretarial Complince Report for the yaer ended 31.03.2026.

2026-05-29 11:05:59
Announcement under Regulation 30 (LODR)-Newspaper Publication

The Company has enclosing herewith copy of newspapers advetiement of financial resulst for the quarter and yaer ended 31.03.2026.

2026-05-22 10:27:43
Result For FY Ended 31.03.2026

Audited Results for fiancial yaer ended 31.03.2026

2026-05-21 13:27:37
Board Meeting Outcome for Outcome Of Board Meeting

Outcome of Board Meeting 21.05.2026

2026-05-21 13:22:41
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Notice is hereby given that meeting of the Board of Directors of the Company will be held on Thursday, May 21, 2026, inter-alia, to consider and adopt the audited financial results for the 4th quarter and financial year ended March 31, 2026.

2026-05-07 15:02:17
Clarification On Price Movement

Clarification on price movement

2026-04-10 10:11:10
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

The Company has enclosing herewith certificate received from RTA under reg 74 (5) of SEBI DP Regulations, 2018 for the quarter ended 31.03.2026.

2026-04-07 10:46:47
Closure of Trading Window

The Company has enclosinh herewith intimation for closure of trading window for considaration of audited financial results for the 4th quarter and year ended 31.03.2026.

2026-03-19 10:46:51
Announcement under Regulation 30 (LODR)-Newspaper Publication

The Company has enclosing copy of newspaper advertisement of financial results for the quarter ended 31.12.2025

2026-02-10 11:56:03

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 10.58 14.89 12.98 11.97 12.89 12.86 11.47 6.10 5.48 4.17 7.27 6.81
YOY Revenue Growth % 6.63% -28.9% 42.75% 4.47% 21.81% -13.67% -11.64% -49.05% -57.48% -67.58% -36.57% 11.62%
Other Income 0.04 0.17 0.03 0.21 0.03 0.09 0.25 0.34 0.01 0.01 0.00 2.00
Total Income 10.62 15.06 13.01 12.18 12.92 12.94 11.72 6.44 5.49 4.17 7.28 8.81
Total Expenses + 15.95 18.64 17.98 18.03 18.09 18.70 19.46 14.69 10.82 10.32 10.41 11.15
Cost of Materials Consumed 1.97 0.63 1.03 1.81 0.37 1.03 1.19 -0.10 0.04 0.00 0.00 0.01
Employee Benefit Expense 4.06 4.09 4.44 3.88 4.25 4.39 4.50 3.45 2.75 2.69 2.69 2.25
Other Expenses 8.77 9.65 9.35 8.32 9.58 8.75 10.37 7.49 4.53 4.27 4.28 5.32
Operating Profit -5.37 -3.75 -5.01 -6.06 -5.20 -5.85 -7.99 -8.59 -5.34 -6.15 -3.13 -4.34
OPM % -50.8% -25.2% -38.6% -50.6% -40.4% -45.5% -69.7% -140.8% -97.4% -147.6% -43% -63.8%
Profit Before Tax + -5.33 -3.57 -4.98 -5.85 -5.17 -5.76 -7.74 -8.25 -5.32 -6.14 -3.13 -2.34
Tax Expense 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.00 0.00 0.00 0.00
Tax % - - - - - - - - - - - -
Profit After Tax -5.33 -3.57 -4.98 -5.85 -5.17 -5.76 -7.74 -8.27 -5.32 -6.14 -3.13 -2.34
EPS (Basic) -2.47 -1.66 -2.31 -2.72 -2.40 -2.67 -3.59 -3.83 -2.47 -2.85 -1.45 -1.09

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Revenue from Operations 23.73 43.31 50.42 52.13 52.94 53.70 33.41
YOY Revenue Growth % -45.21% -14.1% -3.29% -1.52% -1.41% 60.72% -
Other Income 2.03 0.71 0.45 0.62 7.92 0.62 0.37
Total Income 25.76 44.02 50.87 52.75 60.86 54.32 33.78
Total Expenses + 42.69 70.94 70.60 77.45 105.39 82.68 55.36
Cost of Materials Consumed 0.05 2.49 5.43 15.36 46.18 25.62 19.18
Employee Benefit Expense 10.39 16.60 16.47 15.84 15.30 15.83 15.08
Other Expenses 18.40 36.19 36.08 26.39 37.76 29.50 21.10
Operating Profit -18.96 -27.63 -20.18 -25.31 -52.45 -28.98 -21.95
OPM % -79.9% -63.8% -40% -48.6% -99.1% -54% -65.7%
Profit Before Exceptional -16.93 -26.92 -19.73 -24.69 -44.53 -28.36 -28.87
Exceptional Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Profit Before Tax + -16.93 -26.92 -19.73 -24.69 -44.53 -28.36 -28.87
Tax Expense 0.00 0.02 0.00 0.00 0.00 0.00 0.00
Tax % - - - - - - -
Profit After Tax -16.93 -26.94 -19.73 -24.69 -44.53 -28.36 -28.87
EPS (Basic) -7.85 -12.49 -9.16 -11.30 -20.81 -14.53 -16.75

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
ASSETS
Non-Current Assets + 153.62 158.78 160.73 158.92 154.31 137.80 0.00
Property, Plant & Equipment 141.42 145.23 149.30 146.47 137.69 116.26 0.00
Capital Work in Progress 1.59 1.24 0.16 2.24 6.53 10.09 0.00
Non-Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 0.29 0.47 0.66 0.84 1.02 1.66 0.00
Current Assets + 9.62 10.26 17.44 16.06 35.49 21.42 0.00
Inventories 5.70 6.03 9.80 11.95 25.56 16.60 0.00
Trade Receivables 0.00 0.05 1.90 0.53 0.88 0.30 0.00
Cash and Cash Equivalents 0.13 0.14 0.14 0.09 0.10 0.71 0.00
Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity -162.75 -146.24 -119.22 -99.46 -75.09 -42.73 0.00
Equity Share Capital 21.56 21.56 21.56 21.56 21.56 19.62 0.00
Other Equity -184.32 -167.80 -140.78 -121.02 -96.65 -62.35 0.00
Non-Current Liabilities 212.94 211.75 235.56 225.34 186.83 153.76 0.00
Current Liabilities 113.07 103.53 61.83 49.10 78.06 48.19 0.00
Total Liabilities 326.00 315.27 297.39 274.44 264.90 201.95 0.00

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Cash from Operating Activities -1.92 -7.89 2.30 -26.49 -17.22 -11.62 0.00
Cash from Investing Activities -3.64 -4.97 -7.82 -10.87 -22.90 -25.51 0.00
Cash from Financing Activities 5.54 12.86 5.56 37.34 39.51 37.66 0.00
Net Increase/Decrease in Cash -0.01 0.00 0.05 -0.01 -0.61 0.54 0.00